These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8759681)

  • 21. Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus.
    Pohl H; Koch M; Khalifa A; Papanikolaou IS; Scheiner K; Wiedenmann B; Rösch T
    Endoscopy; 2007 Jun; 39(6):492-6. PubMed ID: 17554642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Barrett's epithelium and esophageal adenocarcinoma in scleroderma.
    Niv Y; Abu-Avid S; Yelin A; Liberman Y
    Am J Gastroenterol; 1988 Jul; 83(7):792-3. PubMed ID: 3381814
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical images in gastroenterology. Barrett esophagus of distinctive type and adenocarcinoma].
    Barinagarrementeria Aldatz R; Güitrón Cantú JA
    Rev Gastroenterol Mex; 1997; 62(1):58. PubMed ID: 9190656
    [No Abstract]   [Full Text] [Related]  

  • 24. Adenocarcinoma arising in Barrett's esophagus.
    Davis JB; Peterson MH
    Nebr Med J; 1985 Dec; 70(12):433-5. PubMed ID: 4080025
    [No Abstract]   [Full Text] [Related]  

  • 25. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Squamous reepithelialization after circumferential endoscopic mucosal resection of superficial carcinoma arising in Barrett's esophagus.
    Satodate H; Inoue H; Fukami N; Shiokawa A; Kudo SE
    Endoscopy; 2004 Oct; 36(10):909-12. PubMed ID: 15452789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective multivariate analysis of clinical, endoscopic, and histological factors predictive of the development of Barrett's multifocal high-grade dysplasia or adenocarcinoma.
    Weston AP; Badr AS; Hassanein RS
    Am J Gastroenterol; 1999 Dec; 94(12):3413-9. PubMed ID: 10606296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Reflux esophagitis and Barrett's esophagus].
    Yuguero del Moral L; Ojeda Giménez C; Coma del Corral MJ; Velasco Oses A; Seco Gil JL; del Moral Garcia A; Calvo Fernández S
    Rev Esp Enferm Apar Dig; 1982 May; 61(5):388-97. PubMed ID: 7122953
    [No Abstract]   [Full Text] [Related]  

  • 30. Diagnosing and managing Barrett's esophagus.
    Sampliner RE
    Am J Manag Care; 2000 Oct; 6(16 Suppl):S886-90. PubMed ID: 11184660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery.
    McCarthy M; Wilkinson ML
    Gastrointest Endosc; 1999 Jan; 49(1):129-30. PubMed ID: 10048955
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus.
    Soslow RA; Remotti H; Baergen RN; Altorki NK
    Mod Pathol; 1999 Mar; 12(3):239-50. PubMed ID: 10102608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy for Barrett's esophagus: clinical update.
    Overholt BF; Panjehpour M
    Am J Gastroenterol; 1996 Sep; 91(9):1719-23. PubMed ID: 8792687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Barrett's esophagus.
    Byrd D; McKinley MJ; Floch MH; Nair S
    Gastroenterologist; 1994 Jun; 2(2):160-5. PubMed ID: 8055240
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting surveillance in Barrett's esophagus.
    Hillman L
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
    [No Abstract]   [Full Text] [Related]  

  • 36. Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus.
    Rygiel AM; Milano F; Ten Kate FJ; Schaap A; Wang KK; Peppelenbosch MP; Bergman JJ; Krishnadath KK
    Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1380-5. PubMed ID: 18559552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia].
    Catrambone G; Leoncini G; Iurilli L; Queirolo A; Spinelli A; Taviani M; Mazzarino S
    Minerva Chir; 1999 Oct; 54(10):657-67. PubMed ID: 10575887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptosis and cell proliferation in the metaplasia-dysplasia-carcinoma-sequence of Barrett's esophagus.
    Halm U; Tannapfel A; Breitung B; Breidert M; Wittekind CW; Mössner J
    Hepatogastroenterology; 2000; 47(34):962-6. PubMed ID: 11020858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Barrett's esophagus: the role of laparoscopic fundoplication.
    Abbas AE; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Miller DL; Pairolero PC
    Ann Thorac Surg; 2004 Feb; 77(2):393-6. PubMed ID: 14759403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical implications of Barrett's esophagus.
    Crooks GW; Lichtenstein GR
    Arch Intern Med; 1996 Oct; 156(19):2174-80. PubMed ID: 8885815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.